GENETISURE, created in 2014 (United States), from 274 sister brands and 2617 competing brands. GENETISURE is owned by Agilent Technologies, Inc., listed on the stock exchange of New York GENETISURE is part of the Medical Diagnostics & Research activity sector.
Investment simulator :
Portfolio valuation
Agilent Technologies, Inc.
(GENETISURE)
over 5 years*
USD 239.40